Across TCGA patient cohorts, OR6K3 mutation is significantly associated with the immune_cell of many other genes, with 9 significant associations in total. LUSC shows the largest number of these associations.

The most reproducible OR6K3-associated genes across cancer lineages are CD4+ Tem, HSC, and mv Endothelial cells. Each is linked with OR6K3 in more than 1 cancer types. Because this analysis shows association rather than direction, both OR6K3-to-partner and partner-to-OR6K3 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR6K3→partner) and Y-score (partner→OR6K3) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
CESC	CD4+ Tem →	+0.001	+6.174	.001	.020	3	1
SKCM	HSC →	-0.081	-2.700	.005	.006	2	2
SKCM	mv Endothelial cells →	-0.021	-1.941	.025	.031	3	1
SKCM	Smooth muscle →	+0.100	+1.899	.010	.028	3	1
LUSC	Basophils →	+0.160	+2.584	.005	.011	3	1
LUSC	NKT →	-0.070	-3.459	.015	.005	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 9 associations by consensus.

Exploration

OR6K3 survival (RNA) · tumor vs normal (RNA) · all OR6K3 data types